Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mandibular reconstruction with transforming growth factor-beta1

D A Sherris1, C S Murakami, W F Larrabee

  • 1Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota 55905, USA.

The Laryngoscope
|March 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of spontaneous malignant lymphomas in Japanese macaques (Macaca fuscata).

Veterinary pathology·2014
Same author

What surgeons can/can't do.

Bulletin of the American College of Surgeons·2007
Same author

Intestinal stromal tumors in a simian immunodeficiency virus-infected, simian retrovirus-2 negative rhesus macaque (Macaca mulatta).

Veterinary pathology·2005
Same author

Lower eyelid blepharoplasty: the aging eyelid.

Facial plastic surgery : FPS·2002
Same author

Face lift: the anatomic basis for a safe, long-lasting procedure.

Facial plastic surgery : FPS·2002
Same author

Cervicofacial rhytidectomy after head and neck tumor removal.

The Laryngoscope·2002
Same journal

Discrimination of Pairs of Chemosensory Stimuli in Relation to Respiration.

The Laryngoscope·2026
Same journal

What Safety Precautions Are Recommended When Lasering in the Airway?

The Laryngoscope·2026
Same journal

Success of Anterior Ethmoidal Artery Flaps for Nasal Septal Perforation Repair: A Systematic Review.

The Laryngoscope·2026
Same journal

Laryngeal IgG4-Related Disease: A Systematic Review of Clinical Features and Management.

The Laryngoscope·2026
Same journal

Elevated BMI Is Not Associated With Adverse Outcomes in Open Airway Reconstruction.

The Laryngoscope·2026
Same journal

What is the Most Effective Treatment Approach for Vocal Fold Granuloma?

The Laryngoscope·2026
See all related articles

Adding transforming growth factor-beta1 (TGF-beta1) to demineralized bone matrix (DBM) significantly enhanced bone healing in critical mandibular defects in canines. This combination promoted a solid bone bridge and improved biomechanical strength compared to DBM alone.

Area of Science:

  • Regenerative medicine
  • Biomaterials science
  • Skeletal biology

Background:

  • Critical-sized bone defects pose significant reconstructive challenges, particularly when periosteum is absent.
  • Demineralized bone matrix (DBM) is a common bone graft material, but its efficacy can be limited.
  • Growth factors, such as transforming growth factor-beta1 (TGF-beta1), hold potential for enhancing bone regeneration.

Purpose of the Study:

  • To evaluate the efficacy of combining DBM with TGF-beta1 for reconstructing critical mandibular defects in a canine model.
  • To assess the impact of TGF-beta1 on bone healing, union, and biomechanical strength in the absence of periosteum.

Main Methods:

  • A randomized, blinded, placebo-controlled prospective animal pilot study was conducted.
  • Critical mandibular defects in canines were treated with either DBM alone (control) or DBM plus TGF-beta1.

Related Experiment Videos

  • Radiologic, histologic, and biomechanical assessments were performed at 12 weeks post-implantation.

    • Main Results:

    • A palpable bone bridge formed within 5-6 weeks in the TGF-beta1 group, but not in the control group.
    • Histologic and radiologic analysis revealed a solid bone bridge in the TGF-beta1 group and fibrous union in the control group at 12 weeks.
    • The TGF-beta1 group exhibited significantly greater biomechanical strength (9.9 +/- 2.2 N-m) compared to the control group (0 N-m) (P < 0.02).

    Conclusions:

    • The addition of TGF-beta1 to DBM significantly enhances the healing of critical bone defects lacking periosteum in a canine model.
    • TGF-beta1-augmented DBM promotes robust bone formation and improves biomechanical properties, suggesting its potential as a therapeutic strategy for bone regeneration.